Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
A Study to Compare PK, PD and Safety of CKD-381 and D026 in Healthy Subjects
ClinicalTrials.gov study NCT03558425. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of QL1706 (an Anti-PD-1/CTLA-4 Combined Antibody) Combined With Albumin-bound Paclitaxel and Bevacizumab in the Treatment of Platinum-resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT06509971. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Safety, Tolerability, PK, PD, ADA of Escalating Single Dose of CJ-40002 in Healthy Male Subjects
ClinicalTrials.gov study NCT02146625. IPD Sharing: Not stated. Countries: 0. Publications: 0.
PD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCL
ClinicalTrials.gov study NCT06290622. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
ClinicalTrials.gov study NCT06419205. IPD Sharing: NO. Countries: 1. Publications: 0.
PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer
ClinicalTrials.gov study NCT06842472. IPD Sharing: Not stated. Countries: 0. Publications: 0.
PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial.
ClinicalTrials.gov study NCT06486220. IPD Sharing: NO. Countries: 0. Publications: 0.
QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors
ClinicalTrials.gov study NCT03169738. IPD Sharing: NO. Countries: 0. Publications: 0.
Comparison of Neoadjuvant Cadonilimab Versus Chemotherapy Combined With PD-1 in the Treatment of Resectable Non-Small Cell Lung Cancer With High PD-L1 Expression: A Single-Center, Randomized, Explorat
ClinicalTrials.gov study NCT06946836. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD
ClinicalTrials.gov study NCT00209508. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Clinical Study to Evaluate PK, PD, and PG of Rosuvastatin in the Elderly
ClinicalTrials.gov study NCT03715101. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade
ClinicalTrials.gov study NCT04984018. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer
ClinicalTrials.gov study NCT06858956. IPD Sharing: NO. Countries: 0. Publications: 0.
Effectiveness of MIRT on Hand and Finger Dexterity in PD Patients
ClinicalTrials.gov study NCT03763955. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid Tumors
ClinicalTrials.gov study NCT03266159. IPD Sharing: Not stated. Countries: 0. Publications: 0.
PD-L1-expressing Regulatory T Cells in Localized Prostate Cancer Patients Undergoing Iodine-125 Permanent Brachytherapy
ClinicalTrials.gov study NCT04369508. IPD Sharing: NO. Countries: 0. Publications: 0.
DV Combined With PD-1 and Platinum-based First-line Treatment in Patients With HER2 IHC2+/3+ ESCC
ClinicalTrials.gov study NCT06055153. IPD Sharing: NO. Countries: 0. Publications: 0.
Total Neoadjuvant Treatment for pMMR Locally Advanced Low Rectal Cancer: Anti-PD-1 Antibody With FOLFOXIRI and Preoperative Radiation Therapy
ClinicalTrials.gov study NCT06099951. IPD Sharing: NO. Countries: 0. Publications: 0.
QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy
ClinicalTrials.gov study NCT07141186. IPD Sharing: NO. Countries: 0. Publications: 0.
Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults
ClinicalTrials.gov study NCT07331545. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.